Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-cell Lymphoma

Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.

217 public trials 53 recruiting studies
Refine in advanced search Browse all conditions

Diffuse Large B-cell Lymphoma trial results

Completed

Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma

NCT02268045

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Hosp. Interzonal "R" Carrillo Ciudadela, Bariloche, Argentina
  • Clinica Radiologica del Sur Cipolletti, Río Negro Province, Argentina
  • Clinica Viedma Viedma, Río Negro Province, Argentina
  • Hospital Britanico Buenos Aires, Argentina
View all 87 locations
View Trial Details
Completed

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Lymphomas

NCT02401048

Conditions
Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations
  • Site-0397 Birmingham, Alabama, United States
  • Site-0047 Duarte, California, United States
  • Site-0038 Stanford, California, United States
  • Site-0388 Miami, Florida, United States
View Trial Details
Completed

MEDI4736 Alone and in Combination With Tremelimumab or AZD9150 in Adult Subjects With Relapsed/Refractory DLBCL (D4190C00023)

NCT02549651

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Albuquerque, New Mexico, United States
  • Research Site Durham, North Carolina, United States
View all 13 locations
View Trial Details
Completed

Phase II Study to Evaluate the Combination of Rituximab and DepoCyte® in the C5R Chemotherapy Protocol in Patients Between the Ages of 18 and 60 Years With Primary Cerebral Non-Hodgkin Lymphoma and Systemic Diffuse Large B-cell Lymphoma With Neuromeningeal Invasion at Diagnosis

NCT00553943

Conditions
Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • Hôpital Saint Joseph Arlon, Belgium
  • A. Z. Sint-Jan Bruges, Belgium
  • UCL- Saint Luc Brussels, Belgium
View all 46 locations
View Trial Details

Related conditions